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OBJECTIVES: To describe trends in advance directive
(AD) completion from 2000 to 2010 and to explore the
relationship between AD and hospitalization and hospital
death at the end of life.
DESIGN: Retrospective cohort study.
SETTING: Health and Retirement Study (HRS).
PARTICIPANTS: HRS participants who died between
2000 and 2010 and were aged 60 and older at death
(N = 6,122).
MEASUREMENTS: Trends over time in rates of AD
completion, hospitalization before death, and death in hos-
pital are described. The association between trends in AD
completion and hospital death was then assessed by com-
paring nested, multivariable logistic regression models pre-
dicting the odds of hospital death over time with and
without adjusting for AD status and sociodemographic
characteristics. The complex sampling design was
accounted for in all analyses.
RESULTS: The proportion of decedents with an AD
increased from 47% in 2000 to 72% in 2010. At the same
time, the proportion of decedents with at least one hospi-
talization in the last 2 years of life increased from 52% to
71%, and the proportion dying in the hospital decreased
from 45% to 35%. After adjusting for confounding by
sociodemographic characteristics, the trend in declining
hospital death over the decade was negligibly associated
with the greater use of ADs.
CONCLUSION: There has been a significant increase in
rates of AD completion over the last decade, but this trend
has had little effect upon hospitalization and hospital
death, suggesting that AD completion is unlikely to stem
hospitalization before death. J Am Geriatr Soc 62:706–
710, 2014.
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Advance directives (ADs) summarize preferences forlife-sustaining treatment and surrogate decision-maker
in the event that one loses decisional capacity and requires
medical care. There is robust evidence that ADs achieve
their original intent to protect autonomy; individuals with
ADs are more likely to receive the care and surrogate deci-
sion-maker of their choice1 and less likely to die in the
hospital.2,3 Although ADs were originally designed to pro-
tect autonomy, many hoped that they would also help
stem healthcare expenditures on unwanted, aggressive care
at the end of life.4 There is some evidence that ADs save
money for Medicare, but this effect is limited to individu-
als in high-cost regions of the United States who refuse
aggressive care.2
Still, ADs have gained the attention of governments,
insurers, and healthcare providers as a means of reducing
expenditures on unwanted, invasive end-of-life care. Among
the government-sponsored efforts to encourage AD comple-
tion is the Patient Self-Determination Act (PSDA), which
Congress passed in 1991 to require all Medicare-certified
institutions to inform hospitalized individuals of their right
to complete an AD. Many policy analysts have considered
the PSDA a failure—arguing that it has done little to
improve rates of AD completion or advance care planning
(ACP) conversations.5–7 More recently, Congress considered
bills to mandate ACP conversations, Medicare attempted to
improve physician reimbursement for activities related to
ACP, and private insurers have created incentives to prac-
tices to develop systems for eliciting and documenting ADs.
Although a Pew Research poll from 2005 showed that
only 29% of the general public completed an AD, more-
recent studies suggest that as many as 70% of elderly
adults do so.3 Still, no one has demonstrated that these
numbers are part of a consistent trend over time, and no
one has compared population-based trends in AD comple-
tion with trends in hospitalization and place of death given
the results of other individual-level studies showing an
association between AD status and likelihood of dying in a
hospital. Population-level trend analyses could help policy-
makers understand the potential effects of policy efforts to
promote use of ADs and set realistic benchmarks for
efforts to complete them.
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The current study examined the completion of ADs by
a representative population of older Americans from 2000
to 2010. Trends in AD completion were compared with
trends in hospitalization and hospital death over the same
period of time to gauge the potential effect that ADs have
had on hospital care at the end of life.
METHODS
Data and Study Sample
Data from the Health and Retirement Study (HRS), a
biennial longitudinal survey of a nationally representative
cohort of U.S. adults aged 51 and older, were used.8 For
more details about HRS sampling, data collection proce-
dures, and measures, see8 or http://hrsonline.isr.umich.edu.
The analytical sample included individuals who died
between 2000 and 2010 and were aged 60 and older at
death. Ninety-two percent of these subjects had a proxy
who completed an interview after the subject’s death that
included information about the subject’s use of ADs. Age-
eligible decedents with proxy surveys were not significantly
different in sex or Hispanic status than those without
proxy surveys but were less educated (mean 11.3 vs
12.7 yr) and more likely to be white.
Variables of Interest
The variables of interest came from proxies’ responses to
HRS after death surveys (2002–2010) regarding the dece-
dent’s circumstances at death, specifically, whether the
subject completed a living will (LW) or appointed a surro-
gate decision-maker in writing (durable power of attorney
for health care (DPAHC)). LWs were defined as “written
instructions about the treatment or care decedents wanted
to receive during the final days of their lives.” A DPAHC
was defined as “any legal arrangements for a specific per-
son or persons to make decisions about the decedent’s
care or medical treatment if he or she could not make
those decisions him or herself.” Decedents were consid-
ered to have an AD if the proxy reported that, at the time
of death, the person had a LW, DPAHC, or both. In
initial analyses, the characteristics of these decedents
were compared with those of decedents who had neither a
LW nor a DPAHC. Whether the decedent was hospi-
talized at least once in the 2 years before death (yes/no),
the number of hospitalizations and hospital days in the
2 years before death, and whether the person’s death
occurred in a hospital (yes/no) were also examined. (Ques-
tions used to determine these data are available upon
request.)
Variation in AD and hospital use was examined
according to year of death. Analyses controlled for poten-
tial confounding according to differences across splined
time points in the distribution of patients according to age,
sex, race (white, black, other), marital status (married,
partnered, other), educational attainment (<high school,
high school, ≥some college), and nursing home status
(whether the subject had stayed overnight in a skilled nurs-
ing facility in the last 2 years) to account for demographic
shifts in the population over time. Subjects reported each
of these covariates during interviews before death.
Analyses
Important clinical and sociodemographic characteristics
were tabulated to describe the population of subjects and
their proxies, and trends over time in potential demo-
graphic confounders were examined, stratified according
to AD status. Rates of AD completion were determined
according to year of death, stratified according to type of
AD, using the proportion command in STATA version
12.1 (STATA Corp, College Station, TX). Similarly, rates
of hospitalization before death and the proportion of dece-
dents who died in the hospital were determined. Trends
over time were tested using linear regression.
To measure the magnitude of the effect of ADs on rates
of hospital death over the decade, predicted probabilities
were graphed, and coefficients from four nested, multivari-
able logistic regression models predicting the odds of
hospital death (with and without sociodemographic charac-
teristics and AD status as variables in the model) were com-
pared. The same procedure was followed to estimate the
magnitude of the effect of ADs on rates of hospitalization.
In these models, time was modeled as a linear spline with
three nodes. By modeling time as a spline, any changes in
relationships over time could be identified and depicted with
smooth curves as opposed to jagged polygons. Three nodes
were chosen to obtain the right amount of detail in any fig-
ures drafted, without creating too much “noise.”
In all analyses, HRS’s complex sampling design8 was
accounted for using the sampling weight from the subject’s
last interview before death (while community dwelling) as
listed in the HRS 2010 Tracker File. All statistical analyses
were performed using STATA version 12.1.
Ethical Considerations
The University of Michigan exempted this study from
institutional review board review.
RESULTS
Study Population
The sample included data from proxy interviews for 6,122
individuals who died between 2000 and 2010, of whom
6,005 had AD status available. Decedents were on average
81.0  9.6 years old at death (range 60–111). There were
statistically significant differences between subjects with
and without ADs in sex, race, ethnicity, education, marital
status, and place of death (P < .001) (Table 1).
According to proxy reports, 67% of subjects had a
week or more between the start of the “final illness” and
death. Before death, decedents had heart disease (54%),
depression (48%), cancer (35%), cerebrovascular disease
(25%), lung disease (25%), and memory deficits (48%).
Decedents died in hospitals (38%), homes (27%), and
nursing homes (23%) more often than anywhere else; few
died in hospice facilities (8%).
Characteristics of Proxy Respondents
Proxy respondents were adult children (47%), spouses
(35%), and other relatives (13%) who were interviewed
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over the telephone (41%) or in person (59%). Interviews
occurred a mean of 13.2  8.9 months after the dece-
dent’s death (range 0–76 months); 10% occurred more
than 24 months after the decedent’s death.
AD Authorship
AD data were available for 98% of the sample. Of those
with AD data, 63% had some kind of AD before death;
45% had a LW, 57% had a DPAHC, and 38% had
both. There was a statistically significant increase in the
proportion of individuals with ADs throughout the
decade, from 47% in 2000 to 72% in 2010 (P < .001)
(Figure 1).
DPAHCs were more common than LWs for all
10 years. Although the rates of DPAHCs and LWs
increased over the decade, DPAHC completion rates
increased more rapidly over time (DPAHC: b = 0.023, 95%
confidence interval (CI) = 0.018–0.028; LW: b = 0.014,
95% CI = 0.010–0.018).
Timing of Authorship
For decedents for whom dates of AD completion were pro-
vided, LWs (n = 1,440) and DPAHCs (n = 1,836) were
completed a median of 22 months before death (LW mean
47.6  63.6; DPAHC mean 44.5  58.4). Over the 10-year
period, the time between date of AD completion and death
increased (LWs: b = 1.44, 95% CI = 0.33–2.54,
P = .012; DPAHCs: b = 1.49, 95% CI = 0.52–2.45,
P = .003). For example, in 2000, DPAHCs and LWs were
completed a mean of 36.9 and 51.7 months before death,
respectively. By 2010, DPAHCs and LWs were completed a
mean of 40.3 and 54.6 months before death, respectively.
Trends in Hospitalization and Length of Stay
Over the decade, the odds of hospitalization and the number
of hospitalizations before death increased. The unadjusted
odds of any overnight hospitalization during the 2 years
before death increased from 52% in 2000 to 71% in 2010
(odds ratio (OR) = 1.06, P < .001 per year) (Figure 1).
Similarly, the number of hospitalizations per decedent
increased from a mean of 2.6 in 2000 to 3.4 in 2010
(b = 0.77, 95% CI = 0.04–0.12, P < .001).
During the same period, the number of days spent in
the hospital and the odds of dying in the hospital
decreased. The average number of days in the hospital
during the last 2 years of life decreased from a mean of
21.8 in 2000 to 14.3 in 2010, but this trend was not sta-
tistically significant (b = 0.75, 95% CI = 2.11–0.61).
The proportion of subjects dying in the hospital decreased
from 45% in 2000 to 35% in 2010 (OR = 0.96, 95%
CI = 0.95–0.99, P < .001) (Figure 1).
Relationship Between ADs, Hospitalization, and
Hospital Death
ADs were positively associated with hospitalization but
negatively associated with in-hospital death. Subjects with
ADs had higher adjusted odds of hospitalization (adjusted
OR (aOR) = 1.45, 95% CI = 1.29–1.62, P < .001) but
lower adjusted odds of hospital death (aOR = 0.80, 95%
CI = 0.72–0.89, P < .001).
To determine exactly how much of the decrease in
hospital deaths over the decade was due to trends in AD
Table 1. Population-Weighted Characteristics of Study















Hispanic, % 4 13
Education, %
<High school 33 50
High school 50 39
≥Some college 11 7
Unknown 6 4






Never married 3 4
Place of death, %
Hospital 33 45
Home 26 30
Nursing home 27 17
Hospice 10 5
Assisted living 2 0
Other 2 3
Lived alone at time of death, % 77 69
Nursing facility resident, % 39 24




Age at death, mean (range) 82.3 (60–108) 78.7 (60–111)
Number of living children,
mean (range)
3 (0–22) 4 (0–16)
Counts are not available for population-weighted data. Some totals do not
add to 100% because of rounding. P < .001 for all tabulations.
Figure 1. Population-weighted rates of advance directive com-
pletion, hospitalization, and hospital death in the United
States (2000–2010).
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completion as opposed to sociodemographic shifts in the
population, nested models predicting hospital death with
and without ADs and sociodemographic characteristics
were compared. In models not adjusting for sociodemo-
graphic characteristics, ADs had a mild inverse effect on
odds of dying in the hospital (Appendix S1, Graphs A and
B), especially during the first half of the decade, but after
adjusting for sociodemographic characteristics, the effect
of ADs on hospital death decreased by half (Appendix S1,
Graphs C and D). Table 2 compares coefficients of models
with and without ADs with and without sociodemographic
characteristics.
DISCUSSION
Over the last decade, there has been a 25% increase in AD
completion rates among older Americans to an all time
high of 72% by 2010. Increasing use of DPAHCs, which
were more popular than LWs for each year between 2000
and 2010, seem to be the primary driver of the increase in
rates. In addition to increasing acceptance of ADs over the
decade, these data indicate that people were adopting them
earlier over time—as many as 3 months earlier in 2010
than in 2000.
The increased prevalence of ADs observed is consis-
tent with prior research using proxy- and subject-reported
data.4,5 What is likely to explain these trends? It may be
that these changes are the result of the PSDA, which man-
dates that every institution inform individuals upon admis-
sion of their right to complete an AD. Although it is likely
that this is contributory, the PSDA has been in effect since
1991, and despite this, the AD completion rate in 2000
was only 47%. It is more likely that demographic changes
in the aging population and a shift in society’s familiarity
with ADs and willingness to complete them explain the
trends observed. High-profile stories such as that of Terry
Schiavo11 and the growing collective experience of the
baby boomers has driven this shift.12 Over the decade,
ADs have penetrated public discourse, to the point where
they are dinner conversation at the senior living center,13
are on the nightly news and are searchable on Wikipedia.
Where once many were ignorant of LWs and DPAHCs,9
now the majority of those polled have an accurate under-
standing of what they are.10
In general, the growing popularity of ADs is good
news. Over the last decade, it has been demonstrated that
individuals who complete ADs are more likely to have
their wishes for treatment and surrogate decision-maker
respected.1 There is proof that ADs fulfill the promise to
protect autonomy. Still, many would like ADs to do much
more than ensure that people’s wishes are respected. The
results of the current study should serve as a warning to
those who hope that ADs may, in and of themselves,
reduce rising rates of hospitalization and expenditures at
the end of life.
Studies have demonstrated that individuals with ADs
are less likely to die in a hospital,2 and some might con-
clude from these that ADs prevent hospital death, but the
findings of the current study suggest that the relationship
between ADs and hospital death may not be causative. In
the current study, increasing rates of AD completion did
little to explain decreasing rates of hospital death over the
decade; the same is true for rates of hospitalization.
Given prior evidence that the wishes expressed in a
LW cannot be extrapolated to predict other prefer-
ences,14,15 it seems unlikely that that a piece of paper sum-
marizing one’s wishes for surrogate decision-maker and
life-sustaining treatment would have a large effect on one’s
likelihood of being hospitalized or dying in the hospital.
To stem hospitalization rates, the decisions to hospitalize,
die in hospice, or die in the hospital must be addressed
more directly. It may be that ACP conversations in which
individuals are given the choice not to be hospitalized and
provided with the appropriate support to safely and com-
fortably stay home (e.g., with hospice) are much more
likely to affect hospitalization rates than ADs are; pro-
grams incorporating ADs into a comprehensive program
of ACP show that to be the case.16,17
The authors of the current study believe that these
conclusions accurately represent current experience with
ADs. The sample size was large and representative of
elderly Americans who died between 2000 and 2010, pro-
viding sufficient power and allowing the findings to be
extrapolated to the U.S. population. Nevertheless, there
are limitations that must be considered. Retrospective
proxy reports were relied on for the outcomes of interest,
and this raises concern regarding the accuracy of the data.
Proxies who may also have been the decedents’ surrogate
may have been psychologically driven to report greater
concordance between the person’s wishes and the out-
comes of decision-making, and because many proxies were
surveyed more than 12 months after the subjects’ deaths,
their responses are subject to recall bias. Geography, a var-
iable that has been shown to affect the strength of the rela-
tionship between ADs and hospitalization in high-spending
regions, was not accounted for.2,9 Last, its focus on the
elderly population limits the authors’ ability to make any
conclusions about younger adults.
In short, these findings suggest that ADs are increas-
ingly popular but alone are insufficient to stem increasing
rates of hospitalization or account for increasing rates of
hospital death. Although it is important to continue to
Table 2. Regression Coefficients for Four Nested Logis-




A B C D
Time point 1 0.02 0.00 0.02 0.03
Time point 2 0.06 0.08 0.11 0.12
Time point 3 0.30 0.35 0.38 0.39




Variables included in models: (A) year of death; (B) year of death and
advance directive status; (C) year of death and sociodemographic charac-
teristics; and (D) year of death, sociodemographic characteristics, and
advance directive status. Time points were selected based on a linear
spline of subject’s year of death (Time point 1 = 2000–2003; Time point
2 = 2004–2006; Time point 3 = 2007–2010).
aP<.001.
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encourage ADs (to protect autonomy), those looking to
reshape end-of-life care should create systems that promote
ACP. Future research will need to examine how trends in
ACP affect trends in hospitalization and place of death.
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Additional Supporting Information may be found in the
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